The Female Health Company Announces FHCO Dividend Reinvestment Plan Available Through Computershare
CHICAGO, May 24 /PRNewswire-FirstCall/ -- The Female Health Company (Nasdaq: FHCO) today announced the availability of a Computershare Dividend Reinvestment Plan (DRIP) for investors holding, or who wish to become holders, of common stock of The Female Health Company. The Dividend Reinvestment Plan, which is offered and administered by Computershare Trust Company, N.A. ("Computershare"), and not by FHCO, provides an attractive cost-effective alternative to traditional retail brokerage methods of purchasing, holding and selling FHCO shares. Computershare is the registrar and transfer agent for FHCO common shares.
To participate in the Dividend Reinvestment Plan, you can enroll over the internet at the link below, or you can call 1-800-962-4284.
About The Female Health Company
The Female Health Company, based in Chicago, Illinois, manufactures and markets the FC2 Female Condom® (FC2), which is available in about 100 countries around the world. The Company owns certain worldwide rights to the FC2 Female Condom®, including patents that have been issued in Europe, Canada, Australia, South Africa and Japan and pending in various countries. The FC2 Female Condom® is the only available FDA-approved product controlled by a woman that offers dual protection against sexually transmitted diseases, including HIV/AIDS, and unintended pregnancy. The World Health Organization (WHO) has cleared FC2 for purchase by U.N. agencies.
"Safe Harbor" statement under the Private Securities Litigation Reform Act of 1995:
The statements in this release which are not historical facts are forward-looking statements based upon the Company's current plans and strategies, and reflect the Company's current assessment of the risks and uncertainties related to its business, including such things as product demand and market acceptance; the economic and business environment and the impact of government pressures; currency risks; capacity; efficiency and supply constraints; and other risks detailed in the Company's press releases, shareholder communications and Securities and Exchanges Commission filings. Actual events affecting the Company and the impact of such events on the Company's operations may vary from this currently anticipated.
For more information about the Female Health Company visit the Company's website at http://www.femalehealth.com and http://www.femalecondom.org. If you would like to be added to the Company's e-mail alert list, please send an e-mail to FHCInvestor@femalehealthcompany.com .
SOURCE The Female Health Company